|
Sanofi invests $180 million equity in Owkin's artificial intelligence and federated learning to advance oncology pipeline
|
26 November 2021 |
|
Positive results from the first study of high-dose influenza vaccine with a COVID-19 mRNA booster support co-administration recommendations
|
11 October 2021 |
|
Sanofi to focus its COVID-19 development efforts on the recombinant vaccine candidate
|
29 September 2021 |
|
Sanofi to acquire Translate Bio; advances deployment of mRNA technology across vaccines and therapeutics development
|
05 August 2021 |
|
Sanofi launches dedicated vaccines mRNA Center of Excellence
|
29 June 2021 |
|
Sanofi and GSK COVID-19 vaccine candidate demonstrates strong immune responses across all adult age groups in Phase 2 trial
|
17 May 2021 |
|
Sanofi to help manufacture Moderna COVID-19 vaccine, supporting global supply demands
|
26 April 2021 |
|
Sanofi and Translate Bio initiate Phase 1/2 clinical trial of mRNA COVID-19 vaccine candidate
|
17 March 2021 |
|
Sanofi to provide manufacturing support to Johnson & Johnson for their COVID-19 vaccine to help address global supply demands
|
23 February 2021 |
|
Sanofi to provide support to BioNTech in manufacturing their COVID-19 vaccine to help address public health needs
|
27 January 2021 |